Literature DB >> 28791335

Internalization of Rat FSH and LH/CG Receptors by rec-eCG in CHO-K1 Cells.

Jong-Ju Park1, Hun-Ki Seong1, Jeong-Soo Kim1, Byambaragchaa Munkhzaya1, Myung-Hwa Kang2, Kwan-Sik Min1.   

Abstract

Equine chorionic gonadotropin (eCG) is a unique molecule that elicits the response characteristics of both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in other species. Previous studies from this laboratory had demonstrated that recombinant eCG (rec-eCG) from Chinese hamster ovary (CHO-K1) cells exhibited both FSH- and LH-like activity in rat granulosa and Leydig cells. In this study, we analyzed receptor internalization through rec-eCGs, wild type eCG (eCGβ/α) and mutant eCG (eCGβ/αΔ56) with an N-linked oligosaccharide at Asn56 of the α-subunit. Both the rec-eCGs were obtained from CHO-K1 cells. The agonist activation of receptors was analyzed by measuring stimulation time and concentrations of rec-eCGs. Internalization values in the stably selected rat follicle-stimulating hormone receptor (rFSHR) and rat luteinizing/chorionic gonadotropin receptor (rLH/CGR) were highest at 50 min after stimulation with 10 ng of rec-eCGβ/α. The dose-dependent response was highest when 10 ng of rec-eCGβ/α was used. The deglycosylated eCGβ/αΔ56 mutant did not enhance the agonist-stimulated internalization. We concluded that the state of activation of rFSHR and rLH/CGR could be modulated through agonist-stimulated internalization. Our results suggested that the eLH/CGRs are mostly internalized within 60 min by agonist-stimulation by rec-eCG. We also suggested that the lack of responsiveness of the deglycosylated eCGβ/ αΔ56 was likely because the site of glycosylation played a pivotal role in agonist-stimulated internalization in cells expressing rFSHR and rLH/CGR.

Entities:  

Keywords:  Deglycosylated mutants; Internalization; rFSHR; rLH/CGR; rec-eCGβ/α

Year:  2017        PMID: 28791335      PMCID: PMC5532303          DOI: 10.12717/DR.2017.21.2.111

Source DB:  PubMed          Journal:  Dev Reprod        ISSN: 2465-9525


INTRODUCTION

Equine chorionic gonadotropin (eCG) is a unique member of the gonadotropin family, as it can perform both LH- and FSH-like activity in non-equid species as well (Apparailly and Combarnous, 1994; Chopineau et al., 2001). Members of the glycoprotein family, which includes chorionic gonadotropin (CG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH), comprise two non-covalently linked α- and β-subunits (Min et al., 2004; Park et al., 2010). The β-subunits of eCG and eLH have identical primary structures (Min et al., 1994). Thus, eCG could be an ideal model for studying structure/function relationships of gonadotropins, as it exhibits the properties of both its pituitary and placental counterparts (Guillou and Combarnous, 1983; Galet et al., 2009). In mares, eCG is secreted from binucleate trophoblastic cells, called endometrial cups, in maternal plasma during the first half of equine gestation. These cells detach from the chorionic girdle of the conceptus between days 37–120 of pregnancy (Boeta and Zarco, 2012; Flores-Flores et al., 2014; Conley, 2016). Progesterone has not been detected in the second half of gestation in mares (Conley, 2016). The presence of eCG during pregnancy may have a luteogenic effect, leading to the formation of supplementary CL after 35 days of pregnancy as a result of the ovulation and/or luteinization of dominant follicles at different times (Allen, 2001a). Previous studies on biological activity of rec-eCG, rec-eCGβ/α also had higher in vitro bioactivity than the eLH (Min et al., 1996). Deletion of carboxy-terminal peptides (CTP) from the dimeric eCG induced a 50% decrease in the secretion of the truncated hormone, compared to the wild type (Galet et al., 2000). The protein was truncated downstream of residue 109, which significantly decreased its secretion. Thus, the CTP upstream of the residues of the eCGβ-subunit at the 'seat-belt' region were also involved in the folding and secretion of gonadotropins (Galet et al., 2009). In our previous study, we had produced rec-eCG from CHO-K1 cells, which were shown to exhibit dual LH- and FSH-like activity in rat Leydig and granulosa cells (Min et al., 1996, 2004), which expressed rLH/CGR and rFSHR (Park et al., 2009, 2010; Jeoung et al., 2010). A deletion downstream of amino acid 87 of the eCGα-subunit resulted in it not being secreted into the supernatant of the medium in both the transiently and stably transfected cells (Jeoung et al., 2010). A mutant with a deletion downstream of amino acid 95 of the eCGα-subunit showed no LH-like or FSH-like activities, indicating that the C-terminal region of the eCGα-subunit plays a pivotal role in the activity of cells expressing the rFSHR and rLH/CGR. We had also reported that the amino acid sequence at 94–96 of eCGβ-subunit appeared to be very important for signal transduction of the FSHR (Park et al., 2010). Along with the FSHR, LH/CGR is a member of the rhodopsin-like subfamily of G-protein-coupled receptors (GP CRs), which has been shown to mediate the internalization of its agonist (Segaloff and Ascoli, 1993; Ascoli et al., 2002; Flores-Flores et al., 2014). The internalized receptors are either degraded in lysosomes (Ghinea et al., 1992) or undergo resensitization and reinsertion into the plasma membrane (Ascoli and Segaloff, 1987; Lazari et al., 1998). Thus, the majority of internalized GPCRs are recycled back to the plasma membrane, instead of being routed to the lysosomes. Thus, internalization is thought to play an important role in receptor resensitization, rather than desensitization (Krupnick and Benovic, 1998; Lefkowitz, 1998). We also reported on the function of the deglycosylated rec-eCGs produced from CHO-K1 cells (Min et al., 1996, 2004). However, we did not revealed the specific factors for the reduced biological activity in receptor cells. To better define the involvement of the biological activity of the rec-eCG stimulated cAMP synthesis, we have now analyzed the internalization of the rFSHR and rLH/CGR by deglycosylated rec-eCG. In the present study, we constructed a mammalian expression vector of rFSHR and rLH/CGR. The expressing vectors transfected to CHO-K1 cell and assessed the internalization of rFSHR and LHR by the bound rec-eCGβ/α.

MATERIALS AND METHODS

1. Materials

The expression vector pcDNA3 was purchased from Invirogen (CA, USA). CHO-K1 cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). Endonucleases were Boehringer Mannheim (MA, USA) and Takara (Osaka, Japan). Polymerase chain reaction (PCR) reagents were from Takara (Japan). Ham's F-12, CHO-S-SFM II, Geneticin, Lipofectamine 2000 and fetal bovine serum (FBS) were from Gibco BRL (MD, USA). The QIAprep-Spin plasmid kit was purchased from QIAGEN Inc. (Hilden, Germany). PMSG enzyme-linked im-munosorbent assay (ELISA) kit was from DRG (USA). The pCORON 1000 SP VSV-G tag expression vector, cAMP kit and CypHer 5-labeled anti-VSVG were from GE Healthcare Life Science (Buckinghamshire, UK). The oligonucleotides were synthesized by Green Gene Bio (Seoul, Korea). Fetal bovine serum was from Hyclone laboratories (Utah, USA). Centriplus Centrifugal Filter Devices were purchased from Amicon Bio separations (MA, USA). All other reagents used were from Sigma-Aldrich (USA) and Wako Pure Chemicals (Osaka, Japan).

2. Construction of the tethered eCGβ/α and eCGβ/ αΔ56

cDNAs encoding the tethered eCGβ/α were inserted in the pcDNA3 mammalian expression vector and used as templates to construct the mutants, in which Asn56 (AAC) at the glycosylated site of the α-subunit was substituted for Gln (CAG), as previously reported (Min et al., 2004). The epitope, myc-tag (Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu), inserted into the tethered eCGβ/α and mutant (eCGβ/ αΔ56) between the first and second amino acids in the β-subunit of the mature protein. Site-directed mutagenesis was performed using the three primers method in a single-step PCR (Min et al., 2004). The schematic diagrams of rec-eCGβ/αWT and eCGβ/αΔ56 are shown in Fig. 1. These fragments were digested with EcoR I and Sal I and ligated into the eukaryotic expression vector, pcDNA3. The plasmids were then purified and sequenced in both directions by automated DNA sequencing to ensure that the correct mutations had been introduced (designated as pcDNA3-eCGβ/α; β/αΔ56).
Fig. 1

Fig. 1. Schematic diagram of rec-eCGβ/α and receCGβ/ αΔ56.

The eCG cDNA was ligated into the pcDNA3 mammalian expression vector. Wild type (eCGβ/α) and eCGβ/αΔ56 (deglycosylated at Asn56 in the α-subunit replaced with Gln) were constructed.

Fig. 1. Schematic diagram of rec-eCGβ/α and receCGβ/ αΔ56.

The eCG cDNA was ligated into the pcDNA3 mammalian expression vector. Wild type (eCGβ/α) and eCGβ/αΔ56 (deglycosylated at Asn56 in the α-subunit replaced with Gln) were constructed.

3. Cell culture and functional expression

Cultured CHO-K1 cells were transfected into expression vectors using the liposome transfection method, as pre-viously described (Min et al., 2004). The transfected cells were cultured for 48 h in a serum-free medium (CHO-S-SFM-II) and then harvested and centrifuged at 15,000 rpm for 10 min. The supernatant was collected and stored at −20℃ until the assay. Six to 8 pools of stably transfected cells were selected by incubating the cells in a growth medium [Ham’s F12 medium with 10% FCS, penicillin (100 IU/mL), streptomycin (100 μg/mL) and glutamine (2 mM) supplemented with G418 (800 μg/mL)] for 2–3 weeks after transfection, as previously reported method (Min et al., 2004). The culture medium was centrifuged at 15,000 rpm for 10 min to remove cell debris. The supernatant was collected and concentrated in an Amicon Stirred cell concentrator and stored at −20℃ until the assay.

4. Quantification of rec-eCG proteins

The tethered eCG proteins secreted by the transient transfected CHO-K1 cells and the stable cell lines into serum-free media were collected, and rec-eCG was quantified using the PMSG ELISA (enzyme-linked immunosorbent assay) kit, according to the supplier's protocol (DRG, USA). Briefly, the collected medium was dispensed into wells coated with a monoclonal antibody against unique antigenic site on the eCG molecule. The wells were incubated for 60 min at RT and 100 µL of conjugate was then added into each well. The substrate solution (100 µL) was also added, and the mixture was then incubated for 30 min at RT. Finally, 50 µL stop solution was added to stop the enzymatic reaction. The optical density (OD) of the product solution was read at 450 nm with a micro titer plate reader.

5. Selection of cell lines expressing rLH/CGR and rFSHR

The cDNAs for rLH/CGR and FSHR were cloned and expressed in CHO-K1 cell lines, as previously described (Min et al., 1998; Min, 1999). The receptor cDNAs were subcloned into the eukaryotic expression vector, pCORON 1000 SP VSV-G tag (GE Healthcare Life Science, Buc-kinghamshire, UK), for transfection. Stably transfected cell lines were selected by G418 treatment, as previously described (Min et al., 2004, Seo et al., 2015). Briefly, cloned cells were cultured in standard 96-well microplates at concentrations of 105–106 cells/mL and incubated overnight. Cholera toxin was added and the mixture was incubated for 30 min. Finally, the cyclic AMP kit was used according to the supplier's protocol, and the OD was measured at 630 nm with a microplate reader. The establishment and pro-perties of a clonal cell line expressing vsvg-rLH/CGR-wt [designated as vsvg-rLH/CGR (wt-9)] and one expressing vsvg-rFSH-wt [designated vsvg-rFSHR (wt-7)] were studied based on cAMP responsiveness to an agonist, cholera toxin, as previously reported (Park et al., 2009).

6. Internalization assays of rLH/CG and rFSH receptors by rec-eCGs

A novel assay technology, which relies on the intrinsic ability of cell surface receptors to internalize into acidic endosomal vesicles upon agonist stimulation, was recently reported (Lowe et al., 2015). This technology uses a novel, fluorogenic, pH-sensitive cyanine dye, CypHer 5. It is there- fore ideal for reporting the movement of receptors from the cell surface into the acidic internal endosomes. The rLH/CGR cells and FSHR cells were seeded into a 96-well tissue culture view plate (Perkin Elmer; 6005710, pre-coated with poly-D-lysine) at a density of 2×103 cells/cm2 in a complete Nutrient Mix F-12 Ham’s medium with G418 (700 µg/mL). The cells were incubated at 37℃ overnight until the cells were 20–40% confluent. The supernatant was removed and the cells gently washed twice with Kreb's Ringer Buffer (KRB) (120 mM sodium chloride, 25 mM HEPES, 4.8 mM potassium chloride, 1.2 mM potassium dihydrogen orthophosphate, 1.2 mM magnesium sulphate heptahydrate, and 1.3 mM calcium chloride) at pH 7.4. The culture medium was replaced with 70 µL/ well of KRB. KRB with CypHer5-labeled antibodies (2-5 µg/mL), 1μM Hoechst 33342, and 1% FBS was then added to the plate. After incubating at RT for 10 min, 30 µL of KRB containing the agonist (1, 3, 6, 10, and 20 ng/mL of rec-eCG and 500 ng/mL of cholera toxin) was added to the plate. The mixture was incubated at RT for 60 min, and 75 μL/well of ice-cold 8% paraformaldehyde was then added. After incubating on ice at 4℃ for 20 min, the supernatant was removed and the cells were gently washed twice with PBS. Finally, 100 μL/well of PBS was added. The Cy5-labeled receptors and the Hoechst 33342 were visualized with the In Cell Analyzer 3000 device (GE Healthcare Life Science, Buckinghamshire, UK).

RESULTS

1. Stable expression rec-eCGβ/α and rec-eCGβ/α Δ56

The eCGβ/α and rec-eCGβ/αΔ56 vectors were transfected into CHO-K1 cells and the cells stably expressing genes were then selected with G418 treatment. The rec-eCGs secreted by the stably transfected cells into the serum-free medium were isolated and concentrated. The rec-eCGs were quantified using ELISA. The quantity of rec-eCG obtained from stably transfected cells was about 180-240 mIU/mL. The size of the rec-eCGβ/α protein was found to be approximately 40-45 kDa (data now shown), which was consistent with previous studies (Park et al., 2009, 2010; Jeoung et al., 2010). However, the size of the rec-eCG secreted by the mutant with the deglycosylated Asn56 in the α-subunit was decreased approximately 4-5 kDa.

2. Isolation of CHO-K1 cell lines stably expressing rFSHR and rLH/CGR

The mammalian expression vectors for rFSHR and rLH/ CGR were transfected into CHO-K1 cells. The 10 clones were then isolated by G418 treatment. The cAMP level was determined to evaluate the response for agonist stimulation. The most stimulated cells were rFSHR-7 and rLH/ CGR-9, as shown in Fig. 2. The maximal cAMP responses were 2,100 pmol/mL and 3,500 pmol/mL in the rFSHR and rLH/CGR, respectively.
Fig. 2

Selection of cells expressing rFSHR and rLH/ CGR from stably transfected CHO-K1 cells.

Cloned cells were cultured at concentrations of 105-106 cells/mL. Cholera toxin (100 ng/mL) was added, incubated, and cyclic AMP was analyzed using a cAMP kit.

Selection of cells expressing rFSHR and rLH/ CGR from stably transfected CHO-K1 cells.

Cloned cells were cultured at concentrations of 105-106 cells/mL. Cholera toxin (100 ng/mL) was added, incubated, and cyclic AMP was analyzed using a cAMP kit.

3. Internalization assay results of receptors by rec-eCGs in time- and concentration-dependent manner

The effects of rec-eCGβ/α on the internalization of rFSHR and rLH/CGR in CHO-K1 cells were determined in a time-dependent manner (0–70 min). As shown in Fig. 3A, rFSHR rLH/CGR were most internalized at 50 min after incubating rec-eCGβ/α (10 ng/mL). We also measured the effect of rec-eCGβ/α on the internalization by receptors in a concentration-dependent manner (Fig. 3B), and found that the internalization increased proportional to the concentration of rec-eCGβ/α. The granularity values for both the receptors were found to be 800–900. The results of the agonist activation experiment also suggested that both the receptors were internalized in endosomes. Therefore, we used Cy5-labeled receptors to detect the localization after 60 min of incubation with rec-eCGβ/α (Fig. 4). Next, we analyzed the differences between the effects of rec-eCGβ/α and rec-eCGβ/αΔ56 on stably expressed these receptors (rFSHR-7 and rLH/CGR-9). The results of this analysis showed that the rec-eCGβ/αΔ56 in cells expressing rFSHR and rLH/CGR was completely flat; no agonist-stimulated internalization was induced in either cell type by eCGβ/αΔ56 (Fig. 5A, B). Together, these data suggested that rec-eCGβ/α induced receptor internalization in cells expressing rFSHR and rLH/CGR. However, the mutant with the eCGβ/αΔ56 did not induce this agonist stimulated internalization. Thus, the glycosylation site (Asn56) in the eCGα- subunit played a pivotal role in receptor internalization.
Fig. 3

Internalization results for cells expressing rFSHR and rLH/CGR.

(A) Internalization results for time-dependent (0–70 min) at a fixed rec-eCGβ/α concentration (10 ng/mL) in rFSHR and rLH/CGR. (B) Internalization results for agonist-dependent (1–20 ng/mL). The rLH/CGR cells (wt-9) and FSHR cells (wt-7) cells were seeded at a density of 2×103 cells. The results were visualized using the In Cell Analyzer 3,000 device and the granularity of the receptors internalized into the endosomes was calculated.

Fig. 4

Visualization of internalization results with In Cell Analyzer 3000 device.

The cells were labeled with CypHer5 antibody and the agonist (rec-eCGβ/α) was added, as shown in Fig. 3. The Cy5-labeled receptors and the Hoechst 33342 were visualized using the In Cell Analyzer 3,000 device.

Fig. 5

Internalization results of rec-eCGβ/α and rec-eCGβ/αΔ56 using cells expressing rFSHR and rLH/CGR.

(A) rFSHR cells. (B) rLH/CGR cells. Both rec-eCGβ/α and rec-eCGβ/αΔ56 were induced by stably transfected rFSHR and rLH/CGR cells. Internalization assays were analyzed in a rec-eCGβ/ α-dose-dependent manner, as described in Fig. 3.

Internalization results for cells expressing rFSHR and rLH/CGR.

(A) Internalization results for time-dependent (0–70 min) at a fixed rec-eCGβ/α concentration (10 ng/mL) in rFSHR and rLH/CGR. (B) Internalization results for agonist-dependent (1–20 ng/mL). The rLH/CGR cells (wt-9) and FSHR cells (wt-7) cells were seeded at a density of 2×103 cells. The results were visualized using the In Cell Analyzer 3,000 device and the granularity of the receptors internalized into the endosomes was calculated.

Visualization of internalization results with In Cell Analyzer 3000 device.

The cells were labeled with CypHer5 antibody and the agonist (rec-eCGβ/α) was added, as shown in Fig. 3. The Cy5-labeled receptors and the Hoechst 33342 were visualized using the In Cell Analyzer 3,000 device.

Internalization results of rec-eCGβ/α and rec-eCGβ/αΔ56 using cells expressing rFSHR and rLH/CGR.

(A) rFSHR cells. (B) rLH/CGR cells. Both rec-eCGβ/α and rec-eCGβ/αΔ56 were induced by stably transfected rFSHR and rLH/CGR cells. Internalization assays were analyzed in a rec-eCGβ/ α-dose-dependent manner, as described in Fig. 3.

DISCUSSIONS

The results of the present study showed that rec-eCGβ/α induced the internalization of rFSHR and rLH/CGR in CHO- K1 cell lines that expressed those receptors in a time- and con- centration- dependent manner. We also showed that deglycosylation at Asn56 of the α-subunit of rec-eCGβ/α inhibited this agonist-induced internalization in both cell types. Previous studies have demonstrated that rec-eCGβ/α was expressed in the baculovirus-Sf9 insect cell system, either as a single-chain with the C-terminal of the β-sub-unit fused to the N-terminus of the α-subunit or as non-covalently linked heterodimers with or without polyhistidine tags at various locations (Legardinier et al., 2008). Heterodimeric rec-eCG exhibited the same thermal stability as natural pituitary LH, and its advantages over the single-chain eCG included higher secretion, higher in vitro bioactivity, and lower risk of immunogenicity (Legardinier et al., 2008). From the labeling and pulse-chase experiments, the secretion of the eCGβ-subunit from CHO-K1 cells was inefficient (medium recovery of 16–25%) and slow (t1/2>6.5 h). This secretion of eCGβ-subunit resembled that of hLHβ-subunit, rather than that of the hCGβ-subunit (Cohen et al., 2015). In a previous study, rec-eCG was expressed in commercially available MimicTM insect cells that were stably transformed into Sf9 cells expressing five mammalian genes that encoded glycosyltransferases involved in the synthesis of complex-type monosialylated N-glycans. the rec-eCG produced from these MinicTM insect cells showed mammalian-like nonsialyl complex-type N-glycosylation (Legardinier et al., 2005). Natural eCG contains complex-type N-glycans terminating with both Siaα2,3Gal and Siaα2,6Gal. In previous studies, we had reported rec-eCG production in CHO-K1 cells (Min et al., 2004; Park et al., 2009, 2010; Jeoung et al., 2010). But, the specific glycosylation site is very important for the secretion of rec-eCG in CHO-K1 cells (in preparation). Our results accord to reports that rec-eCG was exhibited biologically activity (Min et al., 1996, 2004; Park et al., 2009, 2010). Taken together, these results indicated that rec-eCG produced from mammalian cells could be useful for improving the development of dominant and pre-ovulation follicles in non-equids. We also stably transfected CHO-K1 cells with rFSHR and rLH/CGR cDNAs. In previous studies, rec-eCGβ/α was shown to have dual activity of both rFSHR and rLH/ CGR in not-equids, but only LH-like activity in equid species (Park et al., 2009; 2010). However, there have been no reports on the internalization of rec-eCGs in rFSHR and rLH/CGR. Our results demonstrated that receptors of rFSH and rLH/CG were internalized in a time- and concentration-dependent manner by rec-eCGs. However, when deglycosylated at the Asn56 of α-subunit, rec-eCG did not induce the internalization of those receptors. Our results support the data from a previous study that showed that the internalization and degradation of chemically deglycosylated hCG (dghCG) was slower than that of hCG in MA-10 cells, and that this effect was not due to its inability to stimulate cAMP production (Hoelscher et al., 1991). In fact, dghCG was not capable of uncoupling the LH/CGR in Leydig tumor cells (Rebois and Fishman, 1983). In contrast to hCG, addition of dghCG to 32P-labeled 293L cells resulted in little or no increase in the phosphorylation of LH/CG receptors (Hipkin et al., 1993). Based on the data presented, we suggested that the rate of the mutant rec-eCG, which was deglycosylated at Asn56 of the α-subunit, was not increased because of the conformation of the hormone-receptor complex. A previous study suggested that four serine residues in the C-terminal tail of rLH/CGR had distinct structural requirements for agonist-induced uncoupling and agonist-induced internalization (Lazari et al., 1998). A constitutive active mutant of hLH/CGR, hLH/CGR- L457R, was not routed to the lysosomes, but was recycled to the cell; hormone degradation was barely detectable (Galet and Ascoli, 2006). Similarly, the removal or simultaneous mutation of two residues (Cys699 and Leu683) rerouted internalized hCG to a degradation pathway and internalized hLHR to the lysosomes (Galet et al., 2004). Replacement of all of the Ser/Thr residues in the carboxyl-terminal tail and truncation of the domain containing these residues completely inhibited vasoactive intestinal polypeptide (VIP)-stimulated phosphorylation and receptor internalization (Langlet et al., 2005). This GPCR internalization has been shown to be agonist-specific and G protein regulated kinase (GRK)-dependent (Hossain et al., 2009). This type of feedback regulation is conventional, as it requires the activation of classic G proteins (Kohout and Lefkowitz, 2003; Lodowski et al., 2003) as shown in Fig. 6. In the presented study, we showed that deglycosylated rec-eCG did not induce agonist-stimulated internalization. Therefore, we suggested that the glycosylation site in rec-eCG played a pivotal role in the internalization of rFSHR and rLH/CGR. The established stable cells expressing rFSHR and rLH/CGR could be utilize agonist-stimulated receptor internalization when stimulated with rec-eCG mutants that were deglycosylated at other sites. Further studies are required to conclusively determine whether internalization is indeed responsible for the uncoupling of rFSHR and rLH/CGR. These activity will be analyze the oocyte ovulation in vivo using mice.
Fig. 6

Pathways of internalization, recycling, degradation and endocytosis of G protein-coupled receptors.

When receptor cells are exposed to a agonist, the responsiveness wanes with time, in spite of the continuous presence of the agonist. It called to as desensitization that occur at the level of the hormone receptor, post-receptor steps. There are two categories of regulatory events. Uncoupling is defined as a change in the functional properties of a constant number of receptors. The other one is down-regulation defining as a reduction in the density of cell surface receptors (Hipkin et al., 1993).

Pathways of internalization, recycling, degradation and endocytosis of G protein-coupled receptors.

When receptor cells are exposed to a agonist, the responsiveness wanes with time, in spite of the continuous presence of the agonist. It called to as desensitization that occur at the level of the hormone receptor, post-receptor steps. There are two categories of regulatory events. Uncoupling is defined as a change in the functional properties of a constant number of receptors. The other one is down-regulation defining as a reduction in the density of cell surface receptors (Hipkin et al., 1993).
  40 in total

1.  The slow rate of internalization of deglycosylated human chorionic gonadotropin is not due to its inability to stimulate cyclic adenosine monophosphate accumulation.

Authors:  S R Hoelscher; M R Sairam; M Ascoli
Journal:  Endocrinology       Date:  1991-06       Impact factor: 4.736

2.  Agonist-induced phosphorylation of the luteinizing hormone/chorionic gonadotropin receptor expressed in a stably transfected cell line.

Authors:  R W Hipkin; J Sánchez-Yagüe; M Ascoli
Journal:  Mol Endocrinol       Date:  1993-07

Review 3.  The lutropin/choriogonadotropin receptor ... 4 years later.

Authors:  D L Segaloff; M Ascoli
Journal:  Endocr Rev       Date:  1993-06       Impact factor: 19.871

4.  Lack of effects of an equine chorionic gonadotropin (eCG) administration between days 9 and 15 postpartum on reproductive performance in a Holstein dairy herd.

Authors:  M Freick; O Passarge; J Weber
Journal:  Reprod Domest Anim       Date:  2017-01-21       Impact factor: 2.005

5.  The recombinant equine LHβ subunit combines divergent intracellular traits of human LHβ and CGβ subunits.

Authors:  Limor Cohen; George R Bousfield; David Ben-Menahem
Journal:  Theriogenology       Date:  2015-01-29       Impact factor: 2.740

6.  Luteogenic and luteotropic effects of eCG during pregnancy in the mare.

Authors:  M Boeta; L Zarco
Journal:  Anim Reprod Sci       Date:  2012-01-21       Impact factor: 2.145

7.  Equine chorionic gonadotropin influence on sheep oocyte in vitro maturation, apoptosis, and follicle-stimulating hormone receptor and luteinizing hormone receptor expression.

Authors:  S C Wei; Z D Gong; H W Zhao; H Q Liang; L J Lai; Y Y Deng
Journal:  Genet Mol Res       Date:  2016-12-02

8.  Comparison of in vitro follicle-stimulating hormone (FSH) activity of equine gonadotropins (luteinizing hormone, FSH, and chorionic gonadotropin) in male and female rats.

Authors:  Y Combarnous; F Guillou; N Martinat
Journal:  Endocrinology       Date:  1984-11       Impact factor: 4.736

9.  Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the Lutropin/Choriogonadotropin receptor.

Authors:  K S Min; X Liu; J Fabritz; J Jaquette; A N Abell; M Ascoli
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

10.  Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.

Authors:  Janet D Lowe; Helen S Sanderson; Alexandra E Cooke; Mehrnoosh Ostovar; Elena Tsisanova; Sarah L Withey; Charles Chavkin; Stephen M Husbands; Eamonn Kelly; Graeme Henderson; Chris P Bailey
Journal:  Mol Pharmacol       Date:  2015-05-26       Impact factor: 4.436

View more
  7 in total

1.  Signal Transduction of Eel Luteinizing Hormone Receptor (eelLHR) and Follicle Stimulating Hormone Receptor (eelFSHR) by Recombinant Equine Chorionic Gonadotropin (rec-eCG) and Native eCG.

Authors:  Munkhzaya Byambaragchaa; So-Yun Lee; Dae-Jung Kim; Myung-Hwa Kang; Kwan-Sik Min
Journal:  Dev Reprod       Date:  2018-03-31

2.  The C-terminal Phosphorylation Sites of eel Follicle-Stimulating Hormone Receptor are Important Role in the Signal Transduction.

Authors:  Jeong-Min Kim; Munkhzaya Byambaragchaa; Myung-Hwa Kang; Kwan-Sik Min
Journal:  Dev Reprod       Date:  2018-06-30

3.  Characterization of tethered equine chorionic gonadotropin and its deglycosylated mutants by ovulation stimulation in mice.

Authors:  Kwan-Sik Min; Jong-Ju Park; Munkhzaya Byambaragchaa; Myung-Hwa Kang
Journal:  BMC Biotechnol       Date:  2019-08-13       Impact factor: 2.563

4.  Comparative gene expression profiling of mouse ovaries upon stimulation with natural equine chorionic gonadotropin (N-eCG) and tethered recombinant-eCG (R-eCG).

Authors:  Kwan-Sik Min; Jong-Ju Park; So-Yun Lee; Munkhzaya Byambaragchaa; Myung-Hwa Kang
Journal:  BMC Biotechnol       Date:  2020-11-11       Impact factor: 2.563

5.  Roles of N-linked and O-linked glycosylation sites in the activity of equine chorionic gonadotropin in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and follicle-stimulating hormone receptor.

Authors:  So-Yun Lee; Munkhzaya Byambaragchaa; Seung-Hee Choi; Han-Ju Kang; Myung-Hwa Kang; Kwan-Sik Min
Journal:  BMC Biotechnol       Date:  2021-09-05       Impact factor: 2.563

6.  Specific Biological Activity of Equine Chorionic Gonadotropin (eCG) Glycosylation Sites in Cells Expressing Equine Luteinizing Hormone/CG (eLH/CG) Receptor.

Authors:  Munkhzaya Byambaragchaa; Seung-Hee Choi; Hyo-Eun Joo; Sang-Gwon Kim; Yean-Ji Kim; Gyeong-Eun Park; Myung-Hwa Kang; Kwan-Sik Min
Journal:  Dev Reprod       Date:  2021-12-31

7.  Signal Transduction of C-Terminal Phosphorylation Regions for Equine Luteinizing Hormone/Chorionic Gonadotropin Receptor (eLH/CGR).

Authors:  Munkhzaya Byambaragchaa; Hyo-Eun Joo; Sang-Gwon Kim; Yean-Ji Kim; Gyeong-Eun Park; Kwan-Sik Min
Journal:  Dev Reprod       Date:  2022-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.